[144] iRhythm Technologies, Inc SEC Filing

Rhea-AI Filing Summary

iRhythm Technologies, Inc. (NASDAQ: IRTC) – Form 144 filing overview

On the latest Form 144 notice, insider Daniel Wilson has disclosed a proposed sale of 3,000 common shares of iRhythm Technologies. The sale will be executed through Morgan Stanley Smith Barney LLC on or about 23 June 2025. Based on the filing’s stated price, the transaction is valued at approximately $450,000.

iRhythm reports 31,925,267 shares outstanding; the proposed sale therefore equals roughly 0.009 % of the company’s issued shares. The shares being sold were originally acquired via company equity awards: 1,063 performance shares (27 Feb 2023), 970 restricted shares (1 Mar 2023) and 967 performance shares (27 Feb 2024).

The filing also lists insider sales during the previous three months: on 2 May 2025, Wilson sold 333 and 1,667 common shares for total gross proceeds of $250,000. The Form 144 certification states that the seller affirms no knowledge of undisclosed material adverse information at the time of filing.

Because the notice covers a relatively small portion of total shares outstanding and does not introduce new corporate information, the immediate market impact is expected to be limited; nevertheless, investors often track insider activity for signalling purposes.

Positive

• Sale volume is only about 0.009 % of outstanding shares, indicating minimal potential impact on share supply.

Negative

• Insider Daniel Wilson filed to sell 3,000 shares worth $450,000, following a 2,000-share sale earlier in the quarter.

Insights

Securities Analyst

TL;DR – Small insider sale (3,000 shares) worth $450k; minimal dilution, neutral information value.

The Form 144 reveals that Daniel Wilson plans to divest 3,000 iRhythm shares, following a 2,000-share sale in May 2025. With nearly 32 million shares outstanding, the upcoming transaction represents less than 0.01 % of float, suggesting negligible supply pressure. No price, earnings or operational data are included, and the filing affirms absence of undisclosed negative information. Insider activity merits monitoring, but the scale and context signal a largely neutral event for valuation.

Corporate Governance Expert

TL;DR – Routine equity award liquidation; governance implications limited.

Wilson’s planned sale involves shares obtained from performance and restricted stock grants, typical for executive compensation. The Form 144 follows compliance requirements, lists broker details, and references Rule 10b5-1 protections. Prior sales were properly disclosed. Given the modest volume and adherence to reporting rules, the filing does not raise governance red flags, although continued insider selling could attract scrutiny if the pace accelerates.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	450000.00	31925267	06/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/27/2023	Performance Shares	ISSUER			1063	02/27/2023	Not Applicable
Common	03/01/2023	Restricted Stock	ISSUER			970	03/01/2023	Not Applicable
Common	02/27/2024	Performance Shares	ISSUER			967	02/27/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANIEL WILSON 699 8th Street Suite 600 San Francisco CA 94103	Common	05/02/2025	333	41625.00
DANIEL WILSON 699 8th Street Suite 600 San Francisco CA 94103	Common	05/02/2025	1667	208375.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many iRhythm (IRTC) shares are being proposed for sale in the Form 144?

3,000 common shares.

What is the aggregate market value of the proposed IRTC share sale?

Approximately $450,000 as stated in the filing.

When is the approximate sale date for the insider transaction?

23 June 2025.

Which broker will execute the iRhythm share sale?

Morgan Stanley Smith Barney LLC.

How many iRhythm shares are outstanding according to the filing?

31,925,267 shares.

Were there recent insider sales prior to this notice?

Yes, Wilson sold 2,000 shares (333 + 1,667) on 2 May 2025 for gross proceeds of $250,000.